BioSpace News Archive

ImmunOs Therapeutics AG, a Swiss bio-technology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer, announced the closing of a Series A financing of CHF 15 million.

Solasia Pharma K.K. announced that it has entered into an exclusive license agreement with Maruho Co., Ltd. for commercialization of Solasia’s product SP-04, a therapeutic agent for chemotherapy induced peripheral neuropathy in Japan..

Octapharma has announced that the final results from the NuProtect study, the largest prospective study of a single factor VIII product in true PUPs with severe haemophilia A, were presented in an oral presentation at the American Society of Hematology 2019 Annual Meeting in Orlando, Florida.

Bioncotech Therapeutics, a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces it has entered into a Phase II clinical trial collaboration with a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A., known as MSD outside the U.S. and Canada..

Investment will be used to scale the company’s patient management platform and enhance care delivery worldwide

Emergex Vaccines Holding Limited, a biotechnology company developing population-based synthetic disease prophylaxis ‘set-point’ vaccines in the field of infectious diseases, announced the successful completion of preclinical testing of its lead vaccine candidate for Dengue Fever.

Unites network biology, artificial intelligence, and technology to power proprietary drug discovery platform

Stilla Technologies, the provider of pioneering digital PCR solutions for high-precision genetic analysis, announced three key hires: Khaled Bahi joins as CFO, with Jerome Leclercq named Senior Vice President for Commercial Operations Europe & Asia and Quang Tran named Quality & Regulatory Affairs Director.

Algernon Pharmaceuticals Inc., a clinical stage pharmaceutical development company, is pleased to announce that it will present at the 12th Annual LD Micro Main Event Conference to be held at the Luxe Sunset Hotel in Los Angeles, CA on December 11th at 2:20 PM Pacific Standard Time.

Doximity released a new national research study on the 2019 labor market for doctors, showing a 5 percent increase in job opportunities for physicians in the U.S. since 2018.